BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12643200)

  • 1. Risk factors for diabetic neuropathy and foot ulceration.
    Adler A
    Curr Diab Rep; 2001 Dec; 1(3):202-7. PubMed ID: 12643200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal changes in the prevalence and associates of foot ulceration in type 2 diabetes: the Fremantle Diabetes Study.
    Baba M; Davis WA; Norman PE; Davis TM
    J Diabetes Complications; 2015 Apr; 29(3):356-61. PubMed ID: 25670409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of neuropathic foot ulcers in individuals with diabetes.
    Sosenko J
    Curr Diab Rep; 2002 Dec; 2(6):477-81. PubMed ID: 12643153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration.
    Murray HJ; Young MJ; Hollis S; Boulton AJ
    Diabet Med; 1996 Nov; 13(11):979-82. PubMed ID: 8946157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of risk factors for diabetic foot ulceration with particular concern to local practice.
    Ahmed AA; Algamdi SA; Alzahrani AM
    Diabetes Metab Syndr; 2015; 9(4):310-5. PubMed ID: 25470648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic neuropathy: is pain God's greatest gift to mankind?
    Boulton AJ
    Semin Vasc Surg; 2012 Jun; 25(2):61-5. PubMed ID: 22817853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study.
    Kumar S; Ashe HA; Parnell LN; Fernando DJ; Tsigos C; Young RJ; Ward JD; Boulton AJ
    Diabet Med; 1994 Jun; 11(5):480-4. PubMed ID: 8088127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of neuropathic foot ulceration in Sri Lankan diabetic patients.
    Fernando DJ
    Ceylon Med J; 1996 Sep; 41(3):96-8. PubMed ID: 8917968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neuropathy and high foot pressures in diabetic foot ulceration.
    Frykberg RG; Lavery LA; Pham H; Harvey C; Harkless L; Veves A
    Diabetes Care; 1998 Oct; 21(10):1714-9. PubMed ID: 9773736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
    Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
    Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foot complications in Type 2 diabetes: an Australian population-based study.
    Tapp RJ; Shaw JE; de Courten MP; Dunstan DW; Welborn TA; Zimmet PZ;
    Diabet Med; 2003 Feb; 20(2):105-13. PubMed ID: 12581261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration.
    Abbott CA; Vileikyte L; Williamson S; Carrington AL; Boulton AJ
    Diabetes Care; 1998 Jul; 21(7):1071-5. PubMed ID: 9653597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
    Pham H; Armstrong DG; Harvey C; Harkless LB; Giurini JM; Veves A
    Diabetes Care; 2000 May; 23(5):606-11. PubMed ID: 10834417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Semmes-Weinstein monofilament in the strong heart study. Risk factors for clinical neuropathy.
    Sosenko JM; Sparling YH; Hu D; Welty T; Howard BV; Lee E; Robbins DC
    Diabetes Care; 1999 Oct; 22(10):1715-21. PubMed ID: 10526741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A multicenter survey on the diabetic foot and its neuropathy in China].
    Lin SD; Lin CJ; Wang AH; Zhao S; Yan L; Wang PH; DU YM; Wang ZJ; Xiao ZH; Ma XY; Chen GC; Zhou YS; Li Q; Bian RW; Mao JP; Xu ZR
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1241-4. PubMed ID: 17686256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes.
    Currie CJ; Morgan CL; Peters JR
    Diabetes Care; 1998 Jan; 21(1):42-8. PubMed ID: 9538969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic neuropathy and foot complications.
    Boulton AJ
    Handb Clin Neurol; 2014; 126():97-107. PubMed ID: 25410217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?
    McNeely MJ; Boyko EJ; Ahroni JH; Stensel VL; Reiber GE; Smith DG; Pecoraro RF
    Diabetes Care; 1995 Feb; 18(2):216-9. PubMed ID: 7729300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic foot complications in Malta: prevalence of risk factors.
    Formosa C; Gatt A; Chockalingam N
    Foot (Edinb); 2012 Dec; 22(4):294-7. PubMed ID: 22981100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in activity may precede diabetic foot ulceration.
    Armstrong DG; Lavery LA; Holtz-Neiderer K; Mohler MJ; Wendel CS; Nixon BP; Boulton AJ
    Diabetes Care; 2004 Aug; 27(8):1980-4. PubMed ID: 15277427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.